Extended Data Fig. 3: HCoV reactivity following third dose of SARS-CoV-2 vaccine.
From: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Antibody responses were studied in four groups of individuals primed with two doses of either ChAdOx1 or BNT162b2, followed by a booster of BNT162b2 or mRNA-1273. Responses were measured by MSD-ECL assay against full-length spike glycoprotein (Spike) from HCoVs 229E, OC43, NL63 and HKU1 and are expressed as MSD arbitrary units (AU/ml). Bar represents group mean.
